Review of anthropometric factors and breast cancer risk

European Journal of Cancer Prevention

Volumn 10, Issue 1, 2001, Pages 15-32

  Friedenreich, C M ^a  

^a Division of Epidemiology   (Canada)

Author keywords

Aetiology; Anthropometric factors; Body mass index; Breast cancer; Cancer prevention; Height; Review; Waist hip ratio; Weight

Indexed keywords

CARCINOGEN; INSULIN; SEX HORMONE; SOMATOMEDIN;

ANTHROPOMETRIC PARAMETERS; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER PREVENTION; CANCER RISK; FEMALE; GENETIC PREDISPOSITION; HUMAN; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WEIGHT GAIN; WEIGHT REDUCTION;

ANTHROPOMETRY; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; OBESITY; RISK FACTORS; SOMATOMEDINS; WEIGHT GAIN;

EID: 0035102316     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200102000-00003     Document Type: Review

References (171)

1. Adipose tissue and aetiology of breast cancer
2. Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population
3. Are cell number and cell proliferation risk factors for cancer?
4. Physical activity and weight gain and fat distribution changes with menopause: Current evidence and research issues
5. Anthropometry and breast cancer. Body size - A moving target
6. Energy balance, anthropometry, and cancer
7. Body weight: Estimation of risk for breast and endometrial cancers
8. Association of change in body mass with breast cancer
9. Body fat distribution and breast cancer in the Framingham Study
10. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States)
11. Endogenous sex hormone levels and breast cancer risk
12. Adolescence and breast carcinoma risk
13. The associations between obesity, adipose tissue distribution and disease
14. Risk factors for breast cancer according to age at diagnosis in a French case-control study
15. Genetic and nongenetic determinants of regional fat distribution in humans
16. Height and weight at various ages and risk of breast cancer
17. Re: Should we consider a subject's knowledge of the etiologic hypotheses in the analysis of case-control studies?
18. Cancer
19. Body measurements, estrogen availability and the risk of human breast cancer - A case-control study
20. Insulin resistance and breast cancer risk
21. Androgen receptors in breast cancer
22. Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial
23. Post-menopausal breast cancer risk: Oral estrogen treatment and abdominal obesity induce opposite changes in possibly important biological variables
24. Obesity as a risk factor for certain types of cancer
25. Bone mineral density and risk of breast cancer in older women
26. The relationship between body mass and breast cancer among women enrolled in the Cancer and Steroid Hormone Study
27. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood
28. A woman's build and the risk of breast cancer
29. Economic costs of obesity and inactivity
30. The association of height, weight, menstrual and reproductive events with breast cancer: Results from two prospective studies on the island of Guernsey (United Kingdom)
31. A prospective study in general practice on breast cancer risk in postmenopausal women
32. On the bimodal age distribution of mammary carcinoma
33. Insulin and related factors in premenopausal breast cancer risk
34. Obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women participating in the Diagnostic Investigation of Mammary Cancer Project
35. A prospective study on obesity and subcutaneous fat patterning in relation to breast cancer in post-menopausal women participating in the DOM project
36. Body fat distribution in relation to breast cancer in women participating in the DOM-project
37. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer
38. The relation of breast size to breast size risk in postmenopausal women (United States)
39. Decrease of circulating levels of SHBG in post-menopausal obese women as a risk factor in breast cancer: Reversible effect of weight loss
40. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolite aberrations in premenopausal women
41. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
42. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts
43. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women
44. Associations of general and abdominal obesity, with multiple health outcomes in older women: The Iowa Women's Health Study
45. Body size indices and breast cancer risk before and after menopause
46. The treatment and prevention of obesity: A systematic review of the literature
47. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors
48. How accurately are height, weight and leg length reported by the elderly, and how closely are they related to measurements recorded in childhood?
49. Relationship of sexhormone binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women
50. Body size and breast cancer risk in black women and white women. The Carolina Breast Cancer Study
51. Circulating concentrations of insulin-like growth factor- and risk of breast cancer
52. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
53. Breast cancer risk: Effects of estrogen replacement therapy and body mass
54. Risk factors for breast cancer
55. Do regular ovulatory cycles increase breast cancer risk?
56. Overview of the determinants of overweight and obesity: Current evidence and research issues
57. Breast size and cancer
58. Breast size, handedness and breast cancer risk
59. Dual effects of weight and weight gain on breast cancer risk
60. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study
61. Diet, body size, and breast cancer
62. Cohort studies of fat intake and the risk of breast cancer - A pooled analysis
63. Obesity and breast disease: The role of the female sex hormones
64. Oestrogen binding and risk factors for breast cancer
65. Does weight cycling present a health risk?
66. A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy
67. Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
68. Nutrition, hormones, and breast cancer: Is insulin the missing link?
69. Breastcancer incidence in relation to height, weight and body-fat distribution in the Dutch 'Dom' cohort
70. Combined effects of childbearing, menstrual events, and body size on age-specific breast cancer risk
71. Breast volumes in cancer of the breast
72. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States)
73. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women
74. Weight and risk for breast cancer
75. Epidemiology and prevention of breast and endometrial cancers
76. Reproductive factors and breast cancer
77. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer
78. Adipose tissue as a medium for epidemiologic exposure assessment
79. Anthropometric indicators of breast cancer risk in postmenopausal women in Hawaii
80. Glucose tolerance and hyperinsulinemia in obese women: Role of adipose tissue distribution, muscle fiber characteristics and androgens
81. Timing of weight gain and breast cancer risk
82. Anthropometric indicators of breast cancer risk in Japanese women in Fukuoka
83. Body size at different periods of life and breast cancer risk
84. Age when maximum height is reached as a risk factor for breast cancer among young U.S. women
85. Anthropometric variables in relation to risk of breast cancer in middle-aged women
86. The relationship of cancer of the female breast to artificial menopause and marital status
87. Prospective study of relative weight, height, and risk of breast cancer
88. The production of mammary cancer in rats using oestrogens
89. The role of endocrine factors and obesity in hormone-dependent gynecological neoplasias
90. Body size in different periods of life and breast cancer risk in postmenopausal women
91. Body size indicators and risk of breast cancer according to menopause and estrogen-receptor status
92. Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S.
93. Exercise clinical trials in cancer prevention research: A call to action
94. The Physical Activity for Total Health (PATH) Study: Rationale and design
95. Changes in circulating steroids with aging in postmenopausal women
96. Population attributable risk for breast cancer: Diet, nutrition, and physical exercise
97. Birthweight as a risk factor for breast cancer
98. The spread of the obesity epidemic in the United States, 1991-1998
99. Serum concentrations of total and non-protein bound oestradiol in patients with breast cancer and in normal controls
100. Is weight cycling detrimental to health? A review of the literature in humans
101. The disease burden associated with overweight and obesity
102. Risk factors for breast carcinoma in Singaporean Chinese women
103. Association between breast cancer and bone mineral density: The Dubbo Osteoporosis Epidemiology study
104. High bone mass as a marker for breast cancer risk
105. Effect of dietary weight loss on sex steroid binding sex steroids, and gonadotropins in obese postmenopausal women
106. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and Hispanic Americans
107. Insulin-like growth factor (IGFs) and IGF binding proteins-1, -2 and -3 in newborn serum: Relationships to fetoplacental growth at term
108. Characteristics that predict risk of breast cancer before and after menopause
109. Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries
110. Relation between obesity and breast cancer in young women
111. Is body fat topography a risk factor for breast cancer?
112. Insulin-like growth factor physiology and cancer risk
113. The obesity epidemic is a worldwide phenomenon
114. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status
115. Effects of weight cycling on body composition
116. Obesity and breast cancer risk
117. Relation between anthropometric indicators and risk of breast cancer among Australian women
118. Pathophysiology of obesity
119. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease
120. Validity of self-reported waist and hip circumferences in men and women
121. Calorie restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumour growth in rats: Alterations in circulation insulin, insulin-like growth factors I and IL and epidermal growth factor
122. Abdominal obesity and breast-cancer risk
123. Estimate of breast cancer risk reduction with weight loss
124. The effect of weight loss on estimated breast cancer risk and sex hormone levels
125. The aging ovary
126. Obesity and cancer risk in women
127. The relationship between breast asymmetry, breast size and the occurrence of breast cancer
128. Effect of family history, body-fat distribution, and reproductive factors on the risk of post-menopausal breast cancer
129. Is breast size a predictor of breast cancer risk or the laterality of the tumor?
130. Risk factors of breast cancer in Finland
131. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in postmenopausal women
132. Obesity and mortality: A review of the epidemiologic data
133. Body fat distribution and obesity in pre- and post-menopausal breast cancer
134. The adipose gene product, leptin: Evidence of a direct inhibitory role in ovarian function
135. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells
136. Does extra height justify a higher risk of breast cancer?
137. Timing of weight gain in relation to breast cancer risk
138. Teenage obesity in relation to breast cancer risk
139. Perimenopausal weight gain and progression of breast cancer precursors
140. Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project
141. Breast cancer risk assessed by anthropometry in the NHANES I Epidemiological Follow-up Study
142. Body size and breast cancer risk among women under age 45 years
143. Genesis and growth of tumors. II. Effects of caloric restriction per se
144. Breast size and breast cancer risk
145. Breast size and mammographic pattern in relation to breast cancer risk
146. Endogenous estrogens and breast cancer risk: The case for prospective cohort studies
147. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years
148. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure
149. Body size and risk of breast cancer
150. Weight change and risk of postmenopausal breast cancer (United States)
151. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway
152. Mammary gland mass and breast cancer risk
153. A meta-analysis of body mass index and risk of premenopausal breast cancer
154. Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67
155. Height, weight, weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study
156. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk
157. Prevalence of obesity
158. Body mass index and risk of breast cancer: A prospective study of 23,826 Norwegian women
159. Prospective study of height, body mass index and risk of breast cancer
160. Breast cancer risk in young women and history of selected medical conditions
161. Relative weight and risk of breast cancer among premenopausal women
162. The 10-year incidence of overweight and major weight gain in US adults
163. Weight cycling in humans: A review of the literature
164. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women
165. Design of the Women's Health Initiative Clinical Trial and Observational Study
166. A study of the epidemiology of cancer of the breast
167. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer
168. Prospective study of relative weight and risk of breast cancer: The Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989
169. Bone mass and the risk of breast cancer among postmenopausal women
170. Anthropometry and breast cancer
171. Relative weight, weight change, height, and breast cancer risk in Asian-American women